MOREADITH RANDALL (Chief Scientific Officer) sold 4K shares of SERINA THERAPEUTICS, INC. on the open market
Open‑market sale worth $12.1K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/21/2026ACC: 0001301120-26-000006
Officer· Chief Scientific Officer
Since Feb 2026
-4K
Net shares
Net seller
$12.1K
Total sold
2
Open market trades
0B · 2S
6
Total transactions
4K acquired · 8K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+2K
Price / share
$0.06
Trade value
$120.00
% of position
New position
1/20/2026
0.00→2K
Common Stock
Direct
Shares
−2K
Price / share
$3.07
Trade value
$6.14K
% of position
New position
1/20/2026
2K→0.00
Common Stock
Direct
Shares
+2K
Price / share
$0.06
Trade value
$120.00
% of position
New position
1/21/2026
0.00→2K
Common Stock
Direct
Shares
−2K
Price / share
$3.00
Trade value
$6K
% of position
New position
1/21/2026
2K→0.00
Total
Net shares
+0.00
Net value
-$11.90K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/20/2026 | M · Option Exercise | +2K | $0.06 | $120.00 | New position | 0.00 | 2K |
| Common Stock Direct | 1/20/2026 | S · Sale | −2K | $3.07 | $6.14K | New position | 2K | 0.00 |
| Common Stock Direct | 1/21/2026 | M · Option Exercise | +2K | $0.06 | $120.00 | New position | 0.00 | 2K |
| Common Stock Direct | 1/21/2026 | S · Sale | −2K | $3.00 | $6K | New position | 2K | 0.00 |
| Total | +0.00 | -$11.90K | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
2K shares
Shares
−2K
Strike price
0.06
Held after
330.69K
Exercisable
—
1/20/2026
Stock Option (right to buy)
Direct
Converts to
Common Stock
2K shares
Shares
−2K
Strike price
0.06
Held after
328.69K
Exercisable
—
1/21/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock2K shares | 1/20/2026 | M · Option Exercise | −2K | 0.06 | — | 330.69K |
| Stock Option (right to buy) Direct | Common Stock2K shares | 1/21/2026 | M · Option Exercise | −2K | 0.06 | — | 328.69K |